Back
Elite Pharmaceuticals Vs. Zevra Therapeutics Industry Stock Comparison
Sell
47
ELTP
Elite Pharmaceuticals
Last Price:
0.54
Seasonality Move:
10.22%
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
8.71
Seasonality Move:
4.71%
Sell
47
Elite Pharmaceuticals (ELTP)
is a Sell
Is Elite Pharmaceuticals a Buy, Sell or Hold?
- The current Elite Pharmaceuticals [ELTP] share price is $0.58. The Score for ELTP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- ELTP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $8.64. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ELTP Stock Price Chart
What is Elite Pharmaceuticals's stock price today?
-
The Elite Pharmaceuticals share price today is $0.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELTP is experiencing slight buying pressure.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $8.64
The current trend is moderately bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELTP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | 86144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.58) | Buy |
| Bollinger Bands (100): | (0.18 - 0.46) | Buy |
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 56.21 | Buy |
| Chaikin Money Flow: | 915695 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.07 - 8.71) | Buy |
| Bollinger Bands (100): | (6 - 8.32) | Buy |
ELTP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.53 | Buy |
| 50-day SMA: | 0.44 | Buy |
| 200-day SMA: | 0.24 | Buy |
| 8-day EMA: | 0.54 | Buy |
| 20-day EMA: | 0.51 | Buy |
| 50-day EMA: | 0.44 | Buy |
| 200-day EMA: | 0.28 | Buy |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.74 | Sell |
| 20-day SMA: | 8.44 | Buy |
| 50-day SMA: | 7.97 | Buy |
| 200-day SMA: | 6.25 | Buy |
| 8-day EMA: | 8.67 | Sell |
| 20-day EMA: | 8.46 | Buy |
| 50-day EMA: | 7.98 | Buy |
| 200-day EMA: | 6.6 | Buy |
Elite Pharmaceuticals Earnings Growth & ELTP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $1.26 per share.
Elite Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zevra Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||